Building Evidence: new tools, new concepts, new methods

• Tran VT, Montori VM, Eton DT, Baruch D, Falissard B, Ravaud P. Development and description of measurement properties of an instrument to assess treatment burden among patients with multiple chronic conditions. BMC Med. 2012;10:68.
• Tran VT, Harrington M, Montori VM, Barnes C, Wicks P, Ravaud P. Adaptation and validation of the Treatment Burden Questionnaire (TBQ) in English using an internet platform. BMC Med. 2014;12:109.
• Tran VT, Barnes C, Montori VM, Falissard B, Ravaud P. Taxonomy of the burden of treatment: a multi-country web-based qualitative study of patients with chronic conditions. BMC Med. 2015;13:115.
• Tran VT, Porcher R, Falissard B, Ravaud P. Point of data saturation was assessed using resampling methods in a survey with open-ended questions. J Clin Epidemiol. 2016;80:88- 96.
• Tran VT, Porcher R, Tran VC, Ravaud P. Predicting data saturation in qualitative surveys
  with mathematical models from ecological research. J Clin Epidemiol. 2017;82:71-8 e2.
  (6) Sidorkiewicz S, Tran VT, Cousyn C, Perrodeau E, Ravaud P. Discordance Between Drug
  Adherence as Reported by Patients and Drug Importance as Assessed by Physicians. Ann
  Fam Med. 2016;14(5):415-21.
• Buffel du Vaure C, Dechartres A, Battin C, Ravaud P, Boutron I. Exclusion of patients with  concomitant chronic conditions in ongoing randomised controlled trials targeting 10 common chronic conditions and registered at ClinicalTrials.gov: a systematic review of registration details. BMJ Open. 2016;6(9):e012265.
• Boutron I, Altman DG, Moher D, Schulz KF, Ravaud P, CONSORT NPT Group. CONSORT Statement for Randomized Trials of Nonpharmacologic Treatments: A 2017 Update and a CONSORT Extension for Nonpharmacologic Trial Abstracts. Ann Intern Med. 2017;167(1):40- 7.
• Lonjon G, Porcher R, Ergina P, Fouet M, Boutron I. Potential Pitfalls of Reporting and Bias in Observational Studies With Propensity Score Analysis Assessing a Surgical Procedure: A Methodological Systematic Review. Ann Surg. 2017;265(5):901-9.
• Lonjon G, Boutron I, Trinquart L, Ahmad N, Aim F, Nizard R, Ravaud P. Comparison of treatment effect estimates from prospective nonrandomized studies with propensity score analysis and randomized controlled trials of surgical procedures. Ann Surg. 2014;259(1):18-
  25.
• Bafeta A, Yavchitz A, Riveros C, Batista R, Ravaud P. Methods and Reporting Studies Assessing Fecal Microbiota Transplantation: A Systematic Review. Ann Intern Med. 2017;167(1):34-9.
• Vivot A, Boutron I, Ravaud P, Porcher R. Guidance for pharmacogenomic biomarker testing in labels of FDA-approved drugs. Genet Med. 2015;17(9):733-8.
• Vivot A, Li J, Zeitoun JD, Mourah S, Crequit P, Ravaud P, Porcher R. Pharmacogenomic biomarkers as inclusion criteria in clinical trials of oncology-targeted drugs: a mapping of ClinicalTrials.gov. Genet Med. 2016;18(8):796-805.
• Vivot A, Jacot J, Zeitoun JD, Ravaud P, Crequit P, Porcher R. Clinical benefit, price and approval characteristics of FDA-approved new drugs for treating advanced solid cancer, 2000-2015. Ann Oncol. 2017;28(5):1111-6.
• Vivot A, Boutron I, Béraud-Chaulet G, Zeitoun JD, Ravaud P, Porcher R. Evidence for treatment-by-biomarker interaction for FDA-approved oncology drugs with required pharmacogenomic biomarker testing. Scientific Reports. 2017.
• Vivot A, Jacot J, Zeitoun JD, Ravaud P, Crequit P, Porcher R. Clinical benefit, price and approval characteristics of FDA-approved new drugs for treating advanced solid cancer, 2000-2015. Ann Oncol. 2017;28(5):1111-6.

Rethinking evidence synthesis

• Baudard M, Yavchitz A, Ravaud P, Perrodeau E, Boutron I. Impact of searching clinical trial  registries in systematic reviews of pharmaceutical treatments: methodological systematic review and reanalysis of meta-analyses. BMJ. 2017;356:j448.
• Boutron I, Dechartres A, Baron G, Li J, Ravaud P. Sharing of Data From Industry-Funded Registered Clinical Trials. JAMA. 2016;315(24):2729-30.
• Nguyen TA, Dechartres A, Belgherbi S, Ravaud P. Public availability of results of trials assessing cancer drugs in the United States. J Clin Oncol. 2013;31(24):2998-3003.
• Maruani A, Boutron I, Baron G, Ravaud P. Impact of sending email reminders of the legal requirement for posting results on ClinicalTrials.gov: cohort embedded pragmatic randomized controlled trial. BMJ. 2014;349:g5579.
• Bafeta A, Dechartres A, Trinquart L, Yavchitz A, Boutron I, Ravaud P. Impact of single centre status on estimates of intervention effects in trials with continuous outcomes: meta-epidemiological study. BMJ. 2012;344:e813.
• Dechartres A, Trinquart L, Boutron I, Ravaud P. Influence of trial sample size on treatment effect estimates: meta-epidemiological study. BMJ. 2013;346:f2304.
• Dechartres A, Ravaud P, Atal I, Riveros C, Boutron I. Association between trial registration and treatment effect estimates: a meta-epidemiological study. BMC Med. 2016;14(1):100.
• Tan A, Porcher R, Crequit P, Ravaud P, Dechartres A. Differences in Treatment Effect Size Between Overall Survival and Progression-Free Survival in Immunotherapy Trials: A MetaEpidemiologic Study of Trials With Results Posted at ClinicalTrials.gov. J Clin Oncol. 2017;35(15):1686-94.
• Trinquart L, Jacot J, Conner SC, Porcher R. Comparison of Treatment Effects Measured by the Hazard Ratio and by the Ratio of Restricted Mean Survival Times in Oncology Randomized Controlled Trials. J Clin Oncol. 2016;34(15):1813-9.
• Dechartres A, Altman DG, Trinquart L, Boutron I, Ravaud P. Association between analytic strategy and estimates of treatment outcomes in meta-analyses. JAMA. 2014;312(6):623- 30.
• Bafeta A, Trinquart L, Seror R, Ravaud P. Analysis of the systematic reviews process in reports of network meta-analyses: methodological systematic review. BMJ. 2013;347:f3675.
• Bafeta A, Trinquart L, Seror R, Ravaud P. Reporting of results from network metaanalyses: methodological systematic review. BMJ. 2014;348:g1741.
• Trinquart L, Attiche N, Bafeta A, Porcher R, Ravaud P. Uncertainty in Treatment Rankings: Reanalysis of Network Meta-analyses of Randomized Trials. Ann Intern Med. 2016;164(10):666-73.
• Crequit P, Trinquart L, Yavchitz A, Ravaud P. Wasted research when systematic reviews fail to provide a complete and up-to-date evidence synthesis: the example of lung cancer. BMC Med. 2016;14:8.

Developing Research on Research

• Yordanov Y, Dechartres A, Porcher R, Boutron I, Altman DG, Ravaud P. Avoidable waste of research related to inadequate methods in clinical trials. BMJ. 2015;350:h809.
• Hopewell S, Ravaud P, Baron G, Boutron I. Effect of editors’ implementation of CONSORT guidelines on the reporting of abstracts in high impact medical journals: interrupted time series analysis. BMJ. 2012;344:e4178.
• Hopewell S, Boutron I, Altman DG, Barbour G, Moher D, Montori V, […], Ravaud P. Impact of a web-based tool (WebCONSORT) to improve the reporting of randomised trials: results of a randomised controlled trial. BMC Med. 2016;14(1):199.
• Barnes C, Boutron I, Giraudeau B, Porcher R, Altman DG, Ravaud P. Impact of an online writing aid tool for writing a randomized trial report: the COBWEB (Consort-based WEB tool) randomized controlled trial. BMC Med. 2015;13:221.
• Riveros C, Dechartres A, Perrodeau E, Haneef R, Boutron I, Ravaud P. Timing and completeness of trial results posted at ClinicalTrials.gov and published in journals. PLoS Med. 2013;10(12):e1001566; discussion e.
• Moher D, Glasziou P, Chalmers I, Nasser M, Bossuyt PM, Korevaar DA, Graham ID, Ravaud P, Boutron I. Increasing value and reducing waste in biomedical research: who’s listening? Lancet. 2016;387(10027):1573-86.
• Dechartres A, Trinquart L, Atal I, Moher D, Dickersin K, Boutron I, Perrodeau E, Altman DG, Ravaud P. Evolution of poor reporting and inadequate methods over time in 20 920 randomised controlled trials included in Cochrane reviews: research on research study. BMJ. 2017;357:j2490.
• Yavchitz A, Ravaud P, Altman DG, Moher D, Hrobjartsson A, Lasserson T, Boutron I. A new classification of spin in systematic reviews and meta-analyses was developed and ranked according to the severity. J Clin Epidemiol. 2016;75:56-65.
• Boutron I, Altman DG, Hopewell S, Vera-Badillo F, Tannock I, Ravaud P. Impact of spin in the abstracts of articles reporting results of randomized controlled trials in the field of cancer: the SPIIN randomized controlled trial. J Clin Oncol. 2014;32(36):4120-6.
• Yavchitz A, Boutron I, Bafeta A, Marroun I, Charles P, Mantz J, Ravaud P. Misrepresentation of randomized controlled trials in press releases and news coverage: a cohort study. PLoS Med. 2012;9(9):e1001308.
• Hopewell S, Collins GS, Boutron I, Yu LM, Cook J, Shanyinde M, et al. Impact of peer review on reports of randomised trials published in open peer review journals: retrospective before and after study. BMJ. 2014;349:g4145.
• Lazarus C, Haneef R, Ravaud P, Hopewell S, Altman DG, Boutron I. Peer reviewers identified spin in manuscripts of nonrandomized studies assessing therapeutic interventions, but their impact on spin in abstract conclusions was limited. J Clin Epidemiol. 2016;77:44-51.
• Bruce R, Chauvin A, Trinquart L, Ravaud P, Boutron I. Impact of interventions to improve the quality of peer review of biomedical journals: a systematic review and meta-analysis. BMC Med. 2016;14(1):85.
• Chauvin A, Ravaud P, Baron G, Barnes C, Boutron I. The most important tasks for peer reviewers evaluating a randomized controlled trial are not congruent with the tasks most often requested by journal editors. BMC Med. 2015;13:158.
• Kovanis M, Porcher R, Ravaud P, Trinquart L. Complex systems approach to scientific publication and peer-review system: development of an agent-based model calibrated with empirical journal data. Scientometrics. 2016;106:695-715.
• Kovanis M, Porcher R, Ravaud P, Trinquart L. The Global Burden of Journal Peer Review in the Biomedical Literature: Strong Imbalance in the Collective Enterprise. PLoS One. 2016;11(11):e0166387.
• Kovanis M, Trinquart L, Ravaud P, Porcher R. Evaluating alternative systems of peer review: a large-scale agent-based modelling approach to scientific publication. Scientometrics. 2017.

Other most significant articles of the team

• Ameur H, Ravaud P, Fayard F, Riveros C, Dechartres A. Systematic reviews of therapeutic interventions frequently consider patient-important outcomes. J Clin Epidemiol. 2017;84:70-7.
• Brunoni AR, Chaimani A, Moffa AH, Razza LB, Gattaz WF, Daskalakis ZJ, Carvalho AF. Repetitive Transcranial Magnetic Stimulation for the Acute Treatment of Major Depressive Episodes: A Systematic Review With Network Meta-analysis. JAMA Psychiatry. 2017;74(2):143-52.
• Chaimani A, Caldwell DM, Li T, Higgins JPT, Salanti G. Additional considerations are required when preparing a protocol for a systematic review with multiple interventions. J Clin Epidemiol. 2017;83:65-74.
• Charlier C, Perrodeau E, Leclercq A, Cazenave B, Pilmis B, Henry B, […], Ravaud P, Lecuit M, Monalisa study group. Clinical features and prognostic factors of listeriosis: the MONALISA national prospective cohort study. Lancet Infect Dis. 2017;17(5):510-9.
• Ndounga Diakou LA, Ntoumi F, Ravaud P, Boutron I. Published randomized trials performed in Sub-Saharan Africa focus on high-burden diseases but are frequently funded and led by high-income countries. J Clin Epidemiol. 2017;82:29-36 e6.
• Nguyen C, Boutron I, Baron G, Sanchez K, Palazzo C, Benchimol R, […] Ravaud P, Rannou F, Poiraudeau S. Intradiscal Glucocorticoid Injection for Patients With Chronic Low Back Pain Associated With Active Discopathy: A Randomized Trial. Ann Intern Med. 2017;166(8):547-56. [COLLABORATION CRESS]
• Perlmutter AS, Tran VT, Dechartres A, Ravaud P. Statistical controversies in clinical research: comparison of primary outcomes in protocols, public clinical-trial registries and publications: the example of oncology trials. Ann Oncol. 2017;28(4):688-95.
• Buffel du Vaure C, Dechartres A, Battin C, Ravaud P, Boutron I. Exclusion of patients with concomitant chronic conditions in ongoing randomised controlled trials targeting 10 common chronic conditions and registered at ClinicalTrials.gov: a systematic review of registration details. BMJ Open. 2016;6(9):e012265.
• Crequit P, Trinquart L, Ravaud P. Live cumulative network meta-analysis: protocol for second-line treatments in advanced non-small-cell lung cancer with wild-type or unknown status for epidermal growth factor receptor. BMJ Open. 2016;6(8):e011841.
• Dechartres A, Bond EG, Scheer J, Riveros C, Atal I, Ravaud P. Reporting of statistically significant results at ClinicalTrials.gov for completed superiority randomized controlled trials. BMC Med. 2016;14(1):192.
• Dechartres A, Riveros C, Harroch M, Faber T, Ravaud P. Characteristics and Public Availability of Results of Clinical Trials on Rare Diseases Registered at Clinicaltrials.gov. JAMA Intern Med. 2016;176(4):556-8.
• Dechartres A, Trinquart L, Faber T, Ravaud P. Empirical evaluation of which trial characteristics are associated with treatment effect estimates. J Clin Epidemiol. 2016;77:24-37.
• Estellat C, Tubach F, Seror R, Alfaiate T, Hajage D, De Rycke Y, Ravaud P. Control treatments in biologics trials of rheumatoid arthritis were often not deemed acceptable in the context of care. J Clin Epidemiol. 2016;69:235-44.
• Faber T, Ravaud P, Riveros C, Perrodeau E, Dechartres A. Meta-analyses including non-randomized studies of therapeutic interventions: a methodological review. BMC Med Res Methodol. 2016;16:35.
• Gottenberg JE, Brocq O, Perdriger A, Lassoued S, Berthelot JM, Wendling D, […], Perrodeau E, Sibilla J, Ravaud P. Non-TNF-Targeted Biologic vs a Second Anti-TNF Drug to Treat Rheumatoid Arthritis in Patients With Insufficient Response to a First Anti-TNF Drug: A Randomized Clinical Trial. JAMA. 2016;316(11):1172-80.
• Mosseri J, Trinquart L, Nizard R, Ravaud P. Meta-Analysis of a Complex Network of Non-Pharmacological Interventions: The Example of Femoral Neck Fracture. PLoS One. 2016;11(1):e0146336.
• Ndounga Diakou LA, Trinquart L, Hrobjartsson A, Barnes C, Yavchitz A, Ravaud P, Boutron I. Comparison of central adjudication of outcomes and onsite outcome assessment on treatment effect estimates. Cochrane Database Syst Rev. 2016;3:MR000043.
• Porcher R, Leyrat C, Baron G, Giraudeau B, Boutron I. Performance of principal scores to estimate the marginal compliers causal effect of an intervention. Stat Med. 2016;35(5):752-67.
• Rousseau A, Rozenberg P, Perrodeau E, Deneux-Tharaux C, Ravaud P. Variations in Postpartum Hemorrhage Management among Midwives: A National Vignette-Based Study. PLoS One. 2016;11(4):e0152863.
• Seror R, Meiners P, Baron G, Bootsma H, Bowman SJ, Vitali C, […], Ravaud P, Mariette X, Eular Sjogren Task Force. Development of the ClinESSDAI: a clinical score without biological domain. A tool for biological studies. Ann Rheum Dis. 2016;75(11):1945-50.
• Sidorkiewicz S, Tran VT, Cousyn C, Perrodeau E, Ravaud P. Development and validation of an instrument to assess treatment adherence for each individual drug taken by a patient. BMJ Open. 2016;6(5):e010510.
• Atal I, Trinquart L, Porcher R, Ravaud P. Differential Globalization of Industry- and Non-Industry-Sponsored Clinical Trials. PLoS One. 2015;10(12):e0145122.
• Dougados M, Soubrier M, Perrodeau E, Gossec L, Fayet F, Gilson M, […], Ravaud P. Impact of a nurse-led programme on comorbidity management and impact of a patient self-assessment of disease activity on the management of rheumatoid arthritis: results of a prospective, multicentre, randomised, controlled trial (COMEDRA). Ann Rheum Dis. 2015;74(9):1725-33.
• Haneef R, Lazarus C, Ravaud P, Yavchitz A, Boutron I. Interpretation of Results of Studies Evaluating an Intervention Highlighted in Google Health News: A Cross-Sectional Study of News. PLoS One. 2015;10(10):e0140889.
• Hopewell S, Boutron I, Altman DG, Ravaud P. Deficiencies in the publication and reporting of the results of systematic reviews presented at scientific medical conferences. J Clin Epidemiol. 2015;68(12):1488-95.
• Lazarus C, Haneef R, Ravaud P, Boutron I. Classification and prevalence of spin in abstracts of non-randomized studies evaluating an intervention. BMC Med Res Methodol. 2015;15:85.
• Regnaux JP, Lefevre-Colau MM, Trinquart L, Nguyen C, Boutron I, Brosseau L, Ravaud P. High-intensity versus low-intensity physical activity or exercise in people with hip or knee osteoarthritis. Cochrane Database Syst Rev. 2015(10):CD010203.
• Rousseau A, Rozenberg P, Ravaud P. Assessing Complex Emergency Management with Clinical Case-Vignettes: A Validation Study. PLoS One. 2015;10(9):e0138663.
• Roze JC, Cambonie G, Marchand-Martin L, Gournay V, Durrmeyer X, Durox M, Storme L, Porcher R, Ancel PY, Hemodynamic Epipage Study Group. Association Between Early Screening for Patent Ductus Arteriosus and In-Hospital Mortality Among Extremely Preterm Infants. JAMA. 2015;313(24):2441-8. [COLLABORATION CRESS]
• Tang E, Ravaud P, Riveros C, Perrodeau E, Dechartres A. Comparison of serious adverse events posted at ClinicalTrials.gov and published in corresponding journal articles. BMC Med. 2015;13:189.
• Villain B, Dechartres A, Boyer P, Ravaud P. Feasibility of individual patient data meta-analyses in orthopaedic surgery. BMC Med. 2015;13:131.
• Biard L, Porcher R, Resche-Rigon M. Permutation tests for centre effect on survival endpoints with application in an acute myeloid leukaemia multicentre study. Stat Med. 2014;33(17):3047-57. [COLLABORATION CRESS]
• Buffel du Vaure C, Boutron I, Perrodeau E, Ravaud P. Reporting funding source or conflict of interest in abstracts of randomized controlled trials, no evidence of a large impact on general practitioners’ confidence in conclusions, a three-arm randomized controlled trial. BMC Med. 2014;12:69.
• Cohen A, Assyag P, Boutron I, Reseau Insuffisance Cardiaque PI. Improving medication adherence and helping patients make lifestyle changes-reply. JAMA Intern Med. 2014;174(10):1708-9.
• Do-Pham G, Le Cleach L, Giraudeau B, Maruani A, Chosidow O, Ravaud P. Designing randomized-controlled trials to improve head-louse treatment: systematic review using a vignette-based method. J Invest Dermatol. 2014;134(3):628-34.
• Gottenberg JE, Ravaud P, Puechal X, Le Guern V, Sibilia J, Goeb V, […], Perrodeau E, Seror R, Mariette X. Effects of hydroxychloroquine on symptomatic improvement in primary Sjogren syndrome: the JOQUER randomized clinical trial. JAMA. 2014;312(3):249-58.
• Hrobjartsson A, Thomsen AS, Emanuelsson F, Tendal B, Rasmussen JV, Hilden J, Boutron I, Ravaud P, Brorson S. Observer bias in randomized clinical trials with time-to-event outcomes: systematic review of trials with both blinded and non-blinded outcome assessors. Int J Epidemiol. 2014;43(3):937-48.
• Thabut G, Mornex JF, Pison C, Cuvelier A, Balduyck M, Pujazon MC, Fournier M, AitIlalne B, Porcher R. Performance of the BODE index in patients with alpha1-antitrypsin deficiency-related COPD. Eur Respir J. 2014;44(1):78-86.
• Trinquart L, Ioannidis JP, Chatellier G, Ravaud P. A test for reporting bias in trial networks: simulation and case studies. BMC Med Res Methodol. 2014;14:112.
• Yavchitz A, Ravaud P, Hopewell S, Baron G, Boutron I. Impact of adding a limitations section to abstracts of systematic reviews on readers’ interpretation: a randomized controlled trial. BMC Med Res Methodol. 2014;14:123.
• Baron G, Perrodeau E, Boutron I, Ravaud P. Reporting of analyses from randomized controlled trials with multiple arms: a systematic review. BMC Med. 2013;11:84.
• Benhamou M, Boutron I, Dalichampt M, Baron G, Alami S, Rannou F, Ravaud P, Poiraudeau, S. Elaboration and validation of a questionnaire assessing patient expectations about management of knee osteoarthritis by their physicians: the Knee Osteoarthritis Expectations Questionnaire. Ann Rheum Dis. 2013;72(4):552-9. [COLLABORATION CRESS]
• Caillard S, Porcher R, Provot F, Dantal J, Choquet S, Durrbach A, et al. Post-transplantation lymphoproliferative disorder after kidney transplantation: report of a nationwide French registry and the development of a new prognostic score. J Clin Oncol. 2013;31(10):1302-9.
• Demmer RT, Trinquart L, Zuk A, Fu BC, Blomkvist J, Michalowicz BS, Ravaud P, Desvarieux M. The influence of anti-infective periodontal treatment on C-reactive protein: a systematic review and meta-analysis of randomized controlled trials. PLoS One. 2013;8(10):e77441.
• Demmer RT, Zuk AM, Rosenbaum M, Desvarieux M. Prevalence of diagnosed and undiagnosed type 2 diabetes mellitus among US adolescents: results from the continuous NHANES, 1999-2010. Am J Epidemiol. 2013;178(7):1106-13.
• Desvarieux M, Boccara F, Meynard JL, Bastard JP, Mallat Z, Charbit B, et al. Infection duration and inflammatory imbalance are associated with atherosclerotic risk in HIV-infected never-smokers independent of antiretroviral therapy. AIDS. 2013;27(16):2603-14.
• Desvarieux M, Demmer RT, Jacobs DR, Papapanou PN, Sacco RL, Rundek T. Changes in clinical and microbiological periodontal profiles relate to progression of carotid intima-media thickness: the Oral Infections and Vascular Disease Epidemiology study. J Am Heart Assoc. 2013;2(6):e000254.
• Gayat E, Thabut G, Christie JD, Mebazaa A, Mary JY, Porcher R. Within-center matching performed better when using propensity score matching to analyze multicenter survival data: empirical and Monte Carlo studies. J Clin Epidemiol. 2013;66(9):1029-37. [COLLABORATION CRESS]
• Hopewell S, Boutron I, Altman DG, Ravaud P. Incorporation of assessments of risk of bias of primary studies in systematic reviews of randomised trials: a cross-sectional study. BMJ Open. 2013;3(8):e003342.
• Mathieu S, Chan AW, Ravaud P. Use of trial register information during the peer review process. PLoS One. 2013;8(4):e59910.
• Rundek T, Blanton SH, Bartels S, Dong C, Raval A, Demmer RT, […], Desvarieux M. Traditional risk factors are not major contributors to the variance in carotid intima-media thickness. Stroke. 2013;44(8):2101-8.
• Seegers V, Trinquart L, Boutron I, Ravaud P. Comparison of treatment effect estimates for pharmacological randomized controlled trials enrolling older adults only and those including adults: a meta-epidemiological study. PLoS One. 2013;8(5):e63677.
• Alkhafaji AA, Trinquart L, Baron G, Desvarieux M, Ravaud P. Impact of evergreening on patients and health insurance: a meta analysis and reimbursement cost analysis of citalopram/escitalopram antidepressants. BMC Med. 2012;10:142.
• Demmer RT, Squillaro A, Papapanou PN, Rosenbaum M, Friedewald WT, Jacobs DR, Jr., Desvarieux M. Periodontal infection, systemic inflammation, and insulin resistance: results from the continuous National Health and Nutrition Examination Survey (NHANES) 1999-2004. Diabetes Care. 2012;35(11):2235-42.
• Estellat C, Ravaud P. Lack of head-to-head trials and fair control arms: randomized controlled trials of biologic treatment for rheumatoid arthritis. Arch Intern Med. 2012;172(3):237-44.
• Gayat E, Resche-Rigon M, Mary JY, Porcher R. Propensity score applied to survival data analysis through proportional hazards models: a Monte Carlo study. Pharm Stat. 2012;11(3):222-9. [COLLABORATION CRESS]
• Gottenberg JE, Ravaud P, Cantagrel A, Combe B, Flipo RM, Schaeverbeke T, […], Pane I, Baron G, Mariette X. Positivity for anti-cyclic citrullinated peptide is associated with a better response to abatacept: data from the ‘Orencia and Rheumatoid Arthritis’ registry. Ann Rheum Dis. 2012;71(11):1815-9.
• Hrobjartsson A, Thomsen AS, Emanuelsson F, Tendal B, Hilden J, Boutron I, Ravaud P, Brorson S. Observer bias in randomised clinical trials with binary outcomes: systematic review of trials with both blinded and non-blinded outcome assessors. BMJ. 2012;344:e1119.
• Konrat C, Boutron I, Trinquart L, Auleley GR, Ricordeau P, Ravaud P. Underrepresentation of elderly people in randomised controlled trials. The example of trials of 4 widely prescribed drugs. PLoS One. 2012;7(3):e33559.
• Mekinian A, Ravaud P, Hatron PY, Larroche C, Leone J, Gombert B, et al. Efficacy of rituximab in primary Sjogren’s syndrome with peripheral nervous system involvement: results from the AIR registry. Ann Rheum Dis. 2012;71(1):84-7.
• Tourabaly I, Boutron I, Nizard R, Ravaud P. ASSIST applicability scoring of surgical trials. an investigator-reported assessment tool. PLoS One. 2012;7(8):e42258.
• Trinquart L, Abbe A, Ravaud P. Impact of reporting bias in network meta-analysis of antidepressant placebo-controlled trials. PLoS One. 2012;7(4):e35219.
• Trinquart L, Chatellier G, Ravaud P. Adjustment for reporting bias in network meta-analysis of antidepressant trials. BMC Med Res Methodol. 2012;12:150.